Abstract
Allergen immunotherapy (AIT) is a specific treatment consisting of repeated administration of allergens with the aim of inducing immunological tolerance. It comprises two subtypes: subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT). According to multiple studies, AIT improves the clinical symptoms, reduces airway hyperresponsiveness, improves asthma control and reduces the need for inhaled corticosteroids (ICS). In addition, this therapy is able to suppress sensitization to new allergens, and if given to patients with allergic rhinitis may even prevent the development of asthma. The effects caused by AIT may be visible for at least several years, even after the therapy has ended (Nakagome et al., 2021).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
